SouthState Corp’s Mesa Laboratories MLAB Stock Holding History

SouthState Corp’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-41	Closed	-$6K	–	718
2022 Q3	$6K	Buy	+41	New	+$7.48K	﹤0.01%	591

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

SouthState Corp's MLAB Position: Q4 2022 in Review

SouthState Corp sold out of Mesa Laboratories (MLAB) in Q4 2022, closing a stake of 41 shares — an estimated $6K sold.

SouthState Corp first reported a position in MLAB in Q3 2022 and held it in 1 quarter. The position peaked at $6K in Q3 2022. 160 funds tracked by Wall St. Rank hold MLAB as of Q4 2022.

SouthState Corp reported no remaining Mesa Laboratories position as of Q4 2022 after selling out during the quarter.
SouthState Corp sold 41 Mesa Laboratories shares in Q4 2022, an estimated $6K.
SouthState Corp first reported a position in Mesa Laboratories in Q3 2022 and held it in 1 quarter.
SouthState Corp's Mesa Laboratories position peaked at $6K in Q3 2022.
160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2022.

Based on SouthState Corp's 13F filing for Q4 2022, filed 10 Feb 2023.